Treatment
Tafenoquine clinical trials
We’re tracking 7 recruiting studies that include Tafenoquine, each written for real people, not researchers, below.
Recruiting studies
- NCT05788094RecruitingPhase 4
Compare two medicines for P. vivax malaria
This study tests how well a malaria treatment plan works for people with P. vivax malaria who don’t have another malaria type at the same time. It aims to see whether adding or using different medicines (ACT vs chloroquine with tafenoquine) helps clear infection and prevent return of disease.
Mae Sot, Changwat TakAges 18 years+ - NCT07052162RecruitingPhase 4
Tafenoquine study in healthy Papua New Guinean children
This study tests how the malaria medicine tafenoquine works in healthy children in Papua New Guinea. It may help find the right dose to prevent malaria safely.
Madang, Madang ProvinceAges 5–12 - NCT04704999RecruitingPhase 4
Testing the right tafenoquine dose for malaria prevention
This study tests the best dose of tafenoquine to treat people with symptoms from a malaria type called P. vivax and to help prevent it from coming back. You may be eligible if you recently had fever and meet specific blood and safety checks, especially G6PD level.
Siem ReapAges 2 years+ - NCT06148792RecruitingPhase 3
Testing a new dose of tafenoquine for vivax malaria
This trial tests a revised dose of a medicine called tafenoquine to more effectively cure vivax malaria (a type of malaria that can come back). It is for people with normal G6PD enzyme levels and a current fever from vivax malaria.
ManausAges 18 years+ - NCT06207370RecruitingPhase 2
Tafenoquine plus standard care for babesiosis
This study tests whether adding the oral drug tafenoquine to standard care works better than standard care plus a placebo for treating babesiosis, a tick-borne illness. You must be hospitalized with active symptoms.
Boston, MassachusettsAges 18 years+ - NCT06666491RecruitingPhase 3
Comparing two malaria treatments for P. vivax in people 2 and older
This study compares two medicines (tafenoquine and primaquine) taken with chloroquine to treat P. vivax malaria. It aims to see which is safer and works better in Indian participants aged 2 to 64.
AhmedabadAges 2–64 - NCT06656351RecruitingPhase 2
Study of tafenoquine for chronic babesiosis with fatigue
This study tests an oral medication, tafenoquine, to see if it helps people with chronic babesiosis who have ongoing fatigue and other symptoms. It aims to find a better treatment for this tick-borne infection that keeps coming back.
New York, New YorkAges 18 years+
What Tafenoquine is being studied for
Conditions with recruiting Tafenoquine studies.
Common questions
- Are there clinical trials studying Tafenoquine?
- Yes. Clin2 currently lists 7 recruiting studies that include Tafenoquine, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Tafenoquine trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Tafenoquine an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Tafenoquine or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.